{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:21:55Z","timestamp":1794007315703,"version":"4.8.0"},"reference-count":218,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41582-026-01241-8","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:26:40Z","timestamp":1784219200000},"page":"564-580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Brain-first and body-first subtypes of Lewy body disease"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6391-8052","authenticated-orcid":false,"given":"Per","family":"Borghammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Van Den Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5796-5442","authenticated-orcid":false,"given":"Daniela","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1407-9640","authenticated-orcid":false,"given":"Ryosuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald B.","family":"Postuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Horsager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"1241_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397, 2284\u20132303 (2021).","journal-title":"Lancet"},{"key":"1241_CR2","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S1474-4422(25)00314-X","volume":"24","author":"A Zarkali","year":"2025","unstructured":"Zarkali, A. et al. Diagnostic and other biomarkers of dementia with Lewy bodies: from research to clinical settings. Lancet Neurol. 24, 1053\u20131065 (2025).","journal-title":"Lancet Neurol."},{"key":"1241_CR3","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/S1474-4422(25)00363-1","volume":"24","author":"SW Scholz","year":"2025","unstructured":"Scholz, S. W. et al. Advances in the genetics and pathology of Lewy body dementia. Lancet Neurol. 24, 1026\u20131037 (2025).","journal-title":"Lancet Neurol."},{"key":"1241_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neurol.2023.11.003","volume":"180","author":"A Pavy-Le Traon","year":"2024","unstructured":"Pavy-Le Traon, A., Foubert-Samier, A. & Fabbri, M. An overview on pure autonomic failure. Rev. Neurol. 180, 94\u2013100 (2024).","journal-title":"Rev. Neurol."},{"key":"1241_CR5","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1474-4422(24)00170-4","volume":"23","author":"A Iranzo","year":"2024","unstructured":"Iranzo, A., Cochen De Cock, V., Fantini, M. L., Perez-Carbonell, L. & Trotti, L. M. Sleep and sleep disorders in people with Parkinson\u2019s disease. Lancet Neurol. 23, 925\u2013937 (2024).","journal-title":"Lancet Neurol."},{"key":"1241_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41582-025-01090-x","volume":"21","author":"Y Fu","year":"2025","unstructured":"Fu, Y. & Halliday, G. M. Dementia with Lewy bodies and Parkinson disease dementia \u2014 the same or different and is it important? Nat. Rev. Neurol. 21, 394\u2013403 (2025).","journal-title":"Nat. Rev. Neurol."},{"key":"1241_CR7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10286-023-00987-1","volume":"33","author":"A Lenka","year":"2023","unstructured":"Lenka, A., Isonaka, R., Holmes, C. & Goldstein, D. S. Cardiac 18F-dopamine positron emission tomography predicts the type of phenoconversion of pure autonomic failure. Clin. Auton. Res. 33, 737\u2013747 (2023).","journal-title":"Clin. Auton. Res."},{"key":"1241_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","volume":"17","author":"D Berg","year":"2021","unstructured":"Berg, D. et al. Prodromal Parkinson disease subtypes \u2014 key to understanding heterogeneity. Nat. Rev. Neurol. 17, 349\u2013361 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"1241_CR9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","volume":"72","author":"SM Fereshtehnejad","year":"2015","unstructured":"Fereshtehnejad, S. M. et al. New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol. 72, 863\u2013873 (2015).","journal-title":"JAMA Neurol."},{"key":"1241_CR10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","volume":"28","author":"GT Stebbins","year":"2013","unstructured":"Stebbins, G. T. et al. How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson\u2019s disease rating scale: comparison with the unified Parkinson\u2019s disease rating scale. Mov. Disord. 28, 668\u2013670 (2013).","journal-title":"Mov. Disord."},{"key":"1241_CR11","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.parkreldis.2015.09.027","volume":"22","author":"A Sauerbier","year":"2016","unstructured":"Sauerbier, A., Jenner, P., Todorova, A. & Chaudhuri, K. R. Non motor subtypes and Parkinson\u2019s disease. Parkinsonism Relat. Disord. 22, S41\u2013S46 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/JPD-202472","volume":"11","author":"TA Mestre","year":"2021","unstructured":"Mestre, T. A. et al. Parkinson\u2019s disease subtypes: critical appraisal and recommendations. J. Parkinson\u2019s Dis. 11, 395\u2013404 (2021).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"1241_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"1241_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"H Braak","year":"2003","unstructured":"Braak, H., Rub, U., Gai, W. P. & Del Tredici, K. Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J. Neural Transm. 110, 517\u2013536 (2003).","journal-title":"J. Neural Transm."},{"key":"1241_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-020-02255-2","volume":"141","author":"J Attems","year":"2021","unstructured":"Attems, J. et al. Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathol. 141, 159\u2013172 (2021).","journal-title":"Acta Neuropathol."},{"key":"1241_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2990.2007.00923.x","volume":"34","author":"ME Kalaitzakis","year":"2008","unstructured":"Kalaitzakis, M. E., Graeber, M. B., Gentleman, S. M. & Pearce, R. K. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson\u2019s disease: a critical analysis of \u03b1-synuclein staging. Neuropathol. Appl. Neurobiol. 34, 284\u2013295 (2008).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"1241_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41531-022-00436-2","volume":"8","author":"P Borghammer","year":"2022","unstructured":"Borghammer, P. et al. A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson\u2019s disease. npj Parkinsons Dis. 8, 166 (2022).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach, T. G. et al. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol. 117, 613\u2013634 (2009).","journal-title":"Acta Neuropathol."},{"key":"1241_CR19","first-page":"S281","volume":"9","author":"P Borghammer","year":"2019","unstructured":"Borghammer, P. & Van Den Berge, N. Brain-first versus gut-first Parkinson\u2019s disease: a hypothesis. J. Parkinsons Dis. 9, S281\u2013S295 (2019).","journal-title":"J. Parkinsons Dis."},{"key":"1241_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3233\/JPD-202481","volume":"11","author":"P Borghammer","year":"2021","unstructured":"Borghammer, P. The \u03b1-Synuclein Origin and Connectome Model (SOC Model) of Parkinson\u2019s disease: explaining motor asymmetry, non-motor phenotypes, and cognitive decline. J. Parkinsons Dis. 11, 455\u2013474 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"1241_CR21","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00702-023-02633-6","volume":"130","author":"P Borghammer","year":"2023","unstructured":"Borghammer, P. The brain-first vs. body-first model of Parkinson\u2019s disease with comparison to alternative models. J. Neural Transm. 130, 737\u2013753 (2023).","journal-title":"J. Neural Transm."},{"key":"1241_CR22","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager, J. et al. Brain-first versus body-first Parkinson\u2019s disease: a multimodal imaging case-control study. Brain 143, 3077\u20133088 (2020).","journal-title":"Brain"},{"key":"1241_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105626","volume":"164","author":"J Horsager","year":"2022","unstructured":"Horsager, J., Knudsen, K. & Sommerauer, M. Clinical and imaging evidence of brain-first and body-first Parkinson\u2019s disease. Neurobiol. Dis. 164, 105626 (2022).","journal-title":"Neurobiol. Dis."},{"key":"1241_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106101","volume":"122","author":"J Horsager","year":"2024","unstructured":"Horsager, J. & Borghammer, P. Brain-first vs. body-first Parkinson\u2019s disease: an update on recent evidence. Parkinsonism Relat. Disord. 122, 106101 (2024).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105557","volume":"161","author":"P Borghammer","year":"2021","unstructured":"Borghammer, P. et al. Neuropathological evidence of body-first vs. brain-first Lewy body disease. Neurobiol. Dis. 161, 105557 (2021).","journal-title":"Neurobiol. Dis."},{"key":"1241_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00018-022-04240-2","volume":"79","author":"GK Tofaris","year":"2022","unstructured":"Tofaris, G. K. Initiation and progression of \u03b1-synuclein pathology in Parkinson\u2019s disease. Cell. Mol. Life Sci. 79, 210 (2022).","journal-title":"Cell. Mol. Life Sci."},{"key":"1241_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41583-020-00416-6","volume":"22","author":"MB Fares","year":"2021","unstructured":"Fares, M. B., Jagannath, S. & Lashuel, H. A. Reverse engineering Lewy bodies: how far have we come and how far can we go? Nat. Rev. Neurosci. 22, 111\u2013131 (2021).","journal-title":"Nat. Rev. Neurosci."},{"key":"1241_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41582-024-01043-w","volume":"21","author":"H Park","year":"2025","unstructured":"Park, H., Kam, T. I., Dawson, V. L. & Dawson, T. M. \u03b1-Synuclein pathology as a target in neurodegenerative diseases. Nat. Rev. Neurol. 21, 32\u201347 (2025).","journal-title":"Nat. Rev. Neurol."},{"key":"1241_CR29","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41593-025-01910-9","volume":"28","author":"KB Andersen","year":"2025","unstructured":"Andersen, K. B. et al. Sympathetic and parasympathetic subtypes of body-first Lewy body disease observed in postmortem tissue from prediagnostic individuals. Nat. Neurosci. 28, 925\u2013936 (2025).","journal-title":"Nat. Neurosci."},{"key":"1241_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70693","volume":"21","author":"LL Gibson","year":"2025","unstructured":"Gibson, L. L. et al. Co-pathology in Alzheimer\u2019s disease and Lewy body disease and its association with neuropsychiatric symptoms. Alzheimers Dement. 21, e70693 (2025).","journal-title":"Alzheimers Dement."},{"key":"1241_CR31","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/mds.26605","volume":"31","author":"CH Adler","year":"2016","unstructured":"Adler, C. H. & Beach, T. G. Neuropathological basis of nonmotor manifestations of Parkinson\u2019s disease. Mov. Disord. 31, 1114\u20131119 (2016).","journal-title":"Mov. Disord."},{"key":"1241_CR32","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00401-019-02071-3","volume":"138","author":"A Raunio","year":"2019","unstructured":"Raunio, A. et al. Lewy-related pathology exhibits two anatomically and genetically distinct progression patterns: a population-based study of Finns aged 85. Acta Neuropathol. 138, 771\u2013782 (2019).","journal-title":"Acta Neuropathol."},{"key":"1241_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s40478-022-01487-5","volume":"10","author":"A Raunio","year":"2022","unstructured":"Raunio, A. et al. Distribution of Lewy-related pathology in the brain, spinal cord, and periphery: the population-based Vantaa 85+ study. Acta Neuropathol. Commun. 10, 178 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"1241_CR34","doi-asserted-by":"publisher","first-page":"E2714","DOI":"10.1073\/pnas.1310233110","volume":"110","author":"J Zhou","year":"2013","unstructured":"Zhou, J. et al. Axon position within the corpus callosum determines contralateral cortical projection. Proc. Natl Acad. Sci. USA 110, E2714\u2013E2723 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1241_CR35","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/cne.902910404","volume":"291","author":"AS Lamantia","year":"1990","unstructured":"Lamantia, A. S. & Rakic, P. Cytological and quantitative characteristics of four cerebral commissures in the rhesus monkey. J. Comp. Neurol. 291, 520\u2013537 (1990).","journal-title":"J. Comp. Neurol."},{"key":"1241_CR36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/ar.1091190109","volume":"119","author":"J Tomasch","year":"1954","unstructured":"Tomasch, J. Size, distribution, and number of fibres in the human corpus callosum. Anat. Rec. 119, 119\u2013135 (1954).","journal-title":"Anat. Rec."},{"key":"1241_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhaa249","author":"N Songthawornpong","year":"2020","unstructured":"Songthawornpong, N., Teasdale, T. W., Olesen, M. V. & Pakkenberg, B. Is there a correlation between the number of brain cells and IQ? Cereb. Cortex https:\/\/doi.org\/10.1093\/cercor\/bhaa249 (2020).","journal-title":"Cereb. Cortex"},{"key":"1241_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13908","author":"F Sixel-Doering","year":"2023","unstructured":"Sixel-Doering, F. et al. The increasing prevalence of REM sleep behavior disorder with Parkinson\u2019s disease progression: a polysomnography-supported study. Mov. Disord. Clin. Pract. https:\/\/doi.org\/10.1002\/mdc3.13908 (2023).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1241_CR39","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1177\/1877718X251364115","volume":"15","author":"L Stefanis","year":"2025","unstructured":"Stefanis, L. & Borghammer, P. Inter-relationship of the age of onset to the concept of brain-first versus body-first Parkinson\u2019s disease. J. Parkinsons Dis. 15, 1312\u20131315 (2025).","journal-title":"J. Parkinsons Dis."},{"key":"1241_CR40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3233\/JPD-240002","volume":"14","author":"P Borghammer","year":"2024","unstructured":"Borghammer, P., Okkels, N. & Weintraub, D. Parkinson\u2019s disease and dementia with Lewy bodies: one and the same. J. Parkinsons Dis. 14, 383\u2013397 (2024).","journal-title":"J. Parkinsons Dis."},{"key":"1241_CR41","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2018.4377","volume":"76","author":"E De Pablo-Fernandez","year":"2019","unstructured":"De Pablo-Fernandez, E., Lees, A. J., Holton, J. L. & Warner, T. T. Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease. JAMA Neurol. 76, 470\u2013479 (2019).","journal-title":"JAMA Neurol."},{"key":"1241_CR42","doi-asserted-by":"publisher","first-page":"zsab067","DOI":"10.1093\/sleep\/zsab067","volume":"44","author":"J Sringean","year":"2021","unstructured":"Sringean, J. et al. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia are more frequent in advanced versus early Parkinson\u2019s disease. Sleep 44, zsab067 (2021).","journal-title":"Sleep"},{"key":"1241_CR43","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","volume":"138","author":"N Van Den Berge","year":"2019","unstructured":"Van Den Berge, N. et al. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of \u03b1-synuclein in rats. Acta Neuropathol. 138, 535\u2013550 (2019).","journal-title":"Acta Neuropathol."},{"key":"1241_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab061","author":"N Van Den Berge","year":"2021","unstructured":"Van Den Berge, N. et al. Ageing promotes pathological \u03b1-synuclein propagation and autonomic dysfunction in wild-type rats. Brain https:\/\/doi.org\/10.1093\/brain\/awab061 (2021).","journal-title":"Brain"},{"key":"1241_CR45","doi-asserted-by":"publisher","first-page":"e92295","DOI":"10.1172\/jci.insight.92295","volume":"2","author":"R Chandra","year":"2017","unstructured":"Chandra, R., Hiniker, A., Kuo, Y. M., Nussbaum, R. L. & Liddle, R. A. \u03b1-Synuclein in gut endocrine cells and its implications for Parkinson\u2019s disease. JCI Insight 2, e92295 (2017).","journal-title":"JCI Insight"},{"key":"1241_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad285","volume":"5","author":"MJ Hurley","year":"2023","unstructured":"Hurley, M. J. et al. \u03b1-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an in vitro proof of concept study. Brain Commun. 5, fcad285 (2023).","journal-title":"Brain Commun."},{"key":"1241_CR47","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.neuron.2016.07.036","volume":"91","author":"JM Kebschull","year":"2016","unstructured":"Kebschull, J. M. et al. High-throughput mapping of single-neuron projections by sequencing of barcoded RNA. Neuron 91, 975\u2013987 (2016).","journal-title":"Neuron"},{"key":"1241_CR48","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/0006-8993(85)90537-2","volume":"329","author":"MT Shipley","year":"1985","unstructured":"Shipley, M. T., Halloran, F. J. & de la Torre, J. Surprisingly rich projection from locus coeruleus to the olfactory bulb in the rat. Brain Res. 329, 294\u2013299 (1985).","journal-title":"Brain Res."},{"key":"1241_CR49","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/cne.901700305","volume":"170","author":"RD Broadwell","year":"1976","unstructured":"Broadwell, R. D. & Jacobowitz, D. M. Olfactory relationships of the telencephalon and diencephalon in the rabbit. III. The ipsilateral centrifugal fibers to the olfactory bulbar and retrobulbar formations. J. Comp. Neurol. 170, 321\u2013345 (1976).","journal-title":"J. Comp. Neurol."},{"key":"1241_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/tox.70041","author":"PHP da Silva","year":"2026","unstructured":"da Silva, P. H. P. et al. Revisiting the Association of Pesticide Exposure and Parkinson\u2019s Disease: systematic review and meta-analysis. Environ. Toxicol. https:\/\/doi.org\/10.1002\/tox.70041 (2026).","journal-title":"Environ. Toxicol."},{"key":"1241_CR51","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3233\/JPD-225047","volume":"13","author":"ER Dorsey","year":"2023","unstructured":"Dorsey, E. R. et al. Trichloroethylene: an invisible cause of Parkinson\u2019s disease? J. Parkinson\u2019s Dis. 13, 203\u2013218 (2023).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"1241_CR52","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/jamaneurol.2023.1168","volume":"80","author":"SM Goldman","year":"2023","unstructured":"Goldman, S. M. et al. Risk of Parkinson disease among service members at marine corps base camp lejeune. JAMA Neurol. 80, 673\u2013681 (2023).","journal-title":"JAMA Neurol."},{"key":"1241_CR53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0041-008X(82)90039-4","volume":"63","author":"I Jakobson","year":"1982","unstructured":"Jakobson, I., Wahlberg, J. E., Holmberg, B. & Johansson, G. Uptake via the blood and elimination of 10 organic solvents following epicutaneous exposure of anesthetized guinea pigs. Toxicol. Appl. Pharmacol. 63, 181\u2013187 (1982).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"1241_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2025.144408","volume":"378","author":"LJL Espartero","year":"2025","unstructured":"Espartero, L. J. L. et al. Dermal permeation of perfluoroalkyl substances in human skin \u2014 an in-vitro study. Chemosphere 378, 144408 (2025).","journal-title":"Chemosphere"},{"key":"1241_CR55","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0887-2333(90)90035-R","volume":"4","author":"RC Scott","year":"1990","unstructured":"Scott, R. C. & Corrigan, M. A. The in vitro percutaneous absorption of diquat: a species comparison. Toxicol. Vitro 4, 137\u2013141 (1990).","journal-title":"Toxicol. Vitro"},{"key":"1241_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53684-3","volume":"9","author":"V Donadio","year":"2019","unstructured":"Donadio, V. et al. The autonomic innervation of hairy skin in humans: an in vivo confocal study. Sci. Rep. 9, 16982 (2019).","journal-title":"Sci. Rep."},{"key":"1241_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00401-020-02233-8","volume":"141","author":"ZI Tanei","year":"2021","unstructured":"Tanei, Z. I. et al. Lewy pathology of the esophagus correlates with the progression of Lewy body disease: a Japanese cohort study of autopsy cases. Acta Neuropathol. 141, 25\u201337 (2021).","journal-title":"Acta Neuropathol."},{"key":"1241_CR58","doi-asserted-by":"publisher","first-page":"fcae148","DOI":"10.1093\/braincomms\/fcae148","volume":"6","author":"T Miyamoto","year":"2024","unstructured":"Miyamoto, T. & Miyamoto, M. Reduced cardiac 123I-MIBG uptake is a robust biomarker of Lewy body disease in isolated rapid eye movement sleep behaviour disorder. Brain Commun. 6, fcae148 (2024).","journal-title":"Brain Commun."},{"key":"1241_CR59","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/brain\/awz030","volume":"142","author":"RB Postuma","year":"2019","unstructured":"Postuma, R. B. et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain 142, 744\u2013759 (2019).","journal-title":"Brain"},{"key":"1241_CR60","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ana.24877","volume":"81","author":"H Kaufmann","year":"2017","unstructured":"Kaufmann, H. et al. Natural history of pure autonomic failure: a United States prospective cohort. Ann. Neurol. 81, 287\u2013297 (2017).","journal-title":"Ann. Neurol."},{"key":"1241_CR61","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1007\/s00415-020-09954-6","volume":"267","author":"A Merola","year":"2020","unstructured":"Merola, A. et al. Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications. J. Neurol. 267, 2949\u20132960 (2020).","journal-title":"J. Neurol."},{"key":"1241_CR62","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.neuron.2016.09.006","volume":"91","author":"EC Ballinger","year":"2016","unstructured":"Ballinger, E. C., Ananth, M., Talmage, D. A. & Role, L. W. Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline. Neuron 91, 1199\u20131218 (2016).","journal-title":"Neuron"},{"key":"1241_CR63","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41583-020-0360-9","volume":"21","author":"GR Poe","year":"2020","unstructured":"Poe, G. R. et al. Locus coeruleus: a new look at the blue spot. Nat. Rev. Neurosci. 21, 644\u2013659 (2020).","journal-title":"Nat. Rev. Neurosci."},{"key":"1241_CR64","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s41105-023-00489-7","volume":"22","author":"Y Luo","year":"2024","unstructured":"Luo, Y., Li, Y. & Yuan, J. The regulation of the pedunculopontine tegmental nucleus in sleep\u2013wake states. Sleep. Biol. Rhythm. 22, 5\u201311 (2024).","journal-title":"Sleep. Biol. Rhythm."},{"key":"1241_CR65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/brain\/awz311","volume":"143","author":"E Matar","year":"2020","unstructured":"Matar, E., Shine, J. M., Halliday, G. M. & Lewis, S. J. G. Cognitive fluctuations in Lewy body dementia: towards a pathophysiological framework. Brain 143, 31\u201346 (2020).","journal-title":"Brain"},{"key":"1241_CR66","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.smrv.2009.10.003","volume":"14","author":"JM Monti","year":"2010","unstructured":"Monti, J. M. The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement (REM) sleep. Sleep. Med. Rev. 14, 319\u2013327 (2010).","journal-title":"Sleep. Med. Rev."},{"key":"1241_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/mds.70202","author":"AE Martinez-Nunez","year":"2026","unstructured":"Martinez-Nunez, A. E. et al. Early autonomic burden in prodromal Parkinson\u2019s disease predicts cognitive impairment. Mov. Disord. https:\/\/doi.org\/10.1002\/mds.70202 (2026).","journal-title":"Mov. Disord."},{"key":"1241_CR68","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3233\/JPD-212570","volume":"11","author":"V Leta","year":"2021","unstructured":"Leta, V. et al. Constipation is associated with development of cognitive impairment in de novo Parkinson\u2019s disease: a longitudinal analysis of two international cohorts. J. Parkinson\u2019s Dis. 11, 1209\u20131219 (2021).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"1241_CR69","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13024-025-00866-5","volume":"20","author":"M Passaretti","year":"2025","unstructured":"Passaretti, M. et al. Clinical progression and genetic pathways in body-first and brain-first Parkinson\u2019s disease. Mol. Neurodegener. 20, 74 (2025).","journal-title":"Mol. Neurodegener."},{"key":"1241_CR70","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41531-024-00730-1","volume":"10","author":"Z Xu","year":"2024","unstructured":"Xu, Z. et al. Disease progression in proposed brain-first and body-first Parkinson\u2019s disease subtypes. npj Parkinsons Dis. 10, 111 (2024).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR71","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00415-025-13050-y","volume":"272","author":"V Velucci","year":"2025","unstructured":"Velucci, V. et al. The natural history of body-first versus brain-first Parkinson\u2019s disease subtypes. J. Neurol. 272, 325 (2025).","journal-title":"J. Neurol."},{"key":"1241_CR72","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/mds.30229","volume":"40","author":"SM Fereshtehnejad","year":"2025","unstructured":"Fereshtehnejad, S. M. et al. Distinct longitudinal clinical\u2013neuroanatomical trajectories in Parkinson\u2019s disease clinical subtypes: insight toward precision medicine. Mov. Disord. 40, 1572\u20131583 (2025).","journal-title":"Mov. Disord."},{"key":"1241_CR73","doi-asserted-by":"publisher","first-page":"431","DOI":"10.5665\/sleep.3468","volume":"37","author":"F Sixel-Doring","year":"2014","unstructured":"Sixel-Doring, F., Trautmann, E., Mollenhauer, B. & Trenkwalder, C. Rapid eye movement sleep behavioral events: a new marker for neurodegeneration in early Parkinson disease? Sleep 37, 431\u2013438 (2014).","journal-title":"Sleep"},{"key":"1241_CR74","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.sleep.2024.01.003","volume":"114","author":"P Perinova","year":"2024","unstructured":"Perinova, P. et al. Comparison of quantitative REM without atonia parameters in isolated REM sleep behavior disorder and early untreated Parkinson\u2019s disease. Sleep Med. 114, 290\u2013296 (2024).","journal-title":"Sleep Med."},{"key":"1241_CR75","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nrneurol.2017.157","volume":"14","author":"B Hogl","year":"2018","unstructured":"Hogl, B., Stefani, A. & Videnovic, A. Idiopathic REM sleep behaviour disorder and neurodegeneration \u2014 an update. Nat. Rev. Neurol. 14, 40\u201355 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"1241_CR76","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1212\/WNL.0b013e3182a6cbd5","volume":"81","author":"B Mollenhauer","year":"2013","unstructured":"Mollenhauer, B. et al. Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort. Neurology 81, 1226\u20131234 (2013).","journal-title":"Neurology"},{"key":"1241_CR77","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41531-024-00642-0","volume":"10","author":"P Dodet","year":"2024","unstructured":"Dodet, P. et al. Sleep disorders in Parkinson\u2019s disease, an early and multiple problem. npj Parkinsons Dis. 10, 46 (2024).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR78","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1007\/s10072-021-05622-3","volume":"43","author":"B Orso","year":"2022","unstructured":"Orso, B. et al. Polysomnographic correlates of sleep disturbances in de novo, drug naive Parkinson\u2019s Disease. Neurol. Sci. 43, 2531\u20132536 (2022).","journal-title":"Neurol. Sci."},{"key":"1241_CR79","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1212\/WNL.51.2.363","volume":"51","author":"BF Boeve","year":"1998","unstructured":"Boeve, B. F. et al. REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease. Neurology 51, 363\u2013370 (1998).","journal-title":"Neurology"},{"key":"1241_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/NRL.0b013e31827c6bdd","volume":"19","author":"WC Pao","year":"2013","unstructured":"Pao, W. C. et al. Polysomnographic findings in dementia with Lewy bodies. Neurologist 19, 1\u20136 (2013).","journal-title":"Neurologist"},{"key":"1241_CR81","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/mds.27997","volume":"35","author":"M van de Beek","year":"2020","unstructured":"van de Beek, M. et al. Prodromal dementia with Lewy Bodies: clinical characterization and predictors of progression. Mov. Disord. 35, 859\u2013867 (2020).","journal-title":"Mov. Disord."},{"key":"1241_CR82","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/alz.12411","volume":"18","author":"P Choudhury","year":"2022","unstructured":"Choudhury, P. et al. The temporal onset of the core features in dementia with Lewy bodies. Alzheimers Dement. 18, 591\u2013601 (2022).","journal-title":"Alzheimers Dement."},{"key":"1241_CR83","doi-asserted-by":"publisher","first-page":"e0243454","DOI":"10.1371\/journal.pone.0243454","volume":"15","author":"H Baumann-Vogel","year":"2020","unstructured":"Baumann-Vogel, H. et al. REM sleep behavior in Parkinson disease: frequent, particularly with higher age. PLoS ONE 15, e0243454 (2020).","journal-title":"PLoS ONE"},{"key":"1241_CR84","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/ana.26670","volume":"94","author":"T Nedelec","year":"2023","unstructured":"Nedelec, T. et al. A comparison between early presentation of dementia with Lewy bodies, Alzheimer\u2019s disease, and Parkinson\u2019s disease: evidence from routine primary care and UK Biobank data. Ann. Neurol. 94, 259\u2013270 (2023).","journal-title":"Ann. Neurol."},{"key":"1241_CR85","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3233\/JPD-230001","volume":"13","author":"TD Fedorova","year":"2023","unstructured":"Fedorova, T. D. et al. Dopaminergic dysfunction is more symmetric in dementia with Lewy bodies compared to Parkinson\u2019s disease. J. Parkinsons Dis. 13, 515\u2013523 (2023).","journal-title":"J. Parkinsons Dis."},{"key":"1241_CR86","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1212\/01.WNL.0000123248.39847.1D","volume":"62","author":"Z Walker","year":"2004","unstructured":"Walker, Z. et al. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison. Neurology 62, 1568\u20131572 (2004).","journal-title":"Neurology"},{"key":"1241_CR87","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1093\/brain\/awaf003","volume":"148","author":"A Delva","year":"2025","unstructured":"Delva, A. et al. Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder. Brain 148, 2049\u20132059 (2025).","journal-title":"Brain"},{"key":"1241_CR88","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias, V., Junn, E. & Mouradian, M. M. The role of oxidative stress in Parkinson\u2019s disease. J. Parkinsons Dis. 3, 461\u2013491 (2013).","journal-title":"J. Parkinsons Dis."},{"key":"1241_CR89","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","volume":"139","author":"A Bose","year":"2016","unstructured":"Bose, A. & Beal, M. F. Mitochondrial dysfunction in Parkinson\u2019s disease. J. Neurochem. 139, 216\u2013231 (2016).","journal-title":"J. Neurochem."},{"key":"1241_CR90","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.expneurol.2017.08.001","volume":"298","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier, D. J., Halliday, G. M. & Simuni, T. Calcium, mitochondrial dysfunction and slowing the progression of Parkinson\u2019s disease. Exp. Neurol. 298, 202\u2013209 (2017).","journal-title":"Exp. Neurol."},{"key":"1241_CR91","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28075","author":"EC Hirsch","year":"2020","unstructured":"Hirsch, E. C. & Standaert, D. G. Ten unsolved questions about neuroinflammation in Parkinson\u2019s disease. Mov. Disord. https:\/\/doi.org\/10.1002\/mds.28075 (2020).","journal-title":"Mov. Disord."},{"key":"1241_CR92","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1093\/brain\/awae177","volume":"147","author":"C Roodveldt","year":"2024","unstructured":"Roodveldt, C. et al. The immune system in Parkinson\u2019s disease: what we know so far. Brain 147, 3306\u20133324 (2024).","journal-title":"Brain"},{"key":"1241_CR93","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-015-1485-1","volume":"131","author":"T Uchihara","year":"2016","unstructured":"Uchihara, T. & Giasson, B. I. Propagation of \u03b1-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol. 131, 49\u201373 (2016).","journal-title":"Acta Neuropathol."},{"key":"1241_CR94","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29897","author":"J Burre","year":"2024","unstructured":"Burre, J. et al. Research priorities on the role of \u03b1-synuclein in Parkinson\u2019s disease pathogenesis. Mov. Disord. https:\/\/doi.org\/10.1002\/mds.29897 (2024).","journal-title":"Mov. Disord."},{"key":"1241_CR95","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00401-022-02403-w","volume":"143","author":"SAM Holec","year":"2022","unstructured":"Holec, S. A. M., Liu, S. L. & Woerman, A. L. Consequences of variability in \u03b1-synuclein fibril structure on strain biology. Acta Neuropathol. 143, 311\u2013330 (2022).","journal-title":"Acta Neuropathol."},{"key":"1241_CR96","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tins.2018.09.007","volume":"42","author":"ME Johnson","year":"2019","unstructured":"Johnson, M. E., Stecher, B., Labrie, V., Brundin, L. & Brundin, P. Triggers, facilitators, and aggravators: redefining Parkinson\u2019s disease pathogenesis. Trends Neurosci. 42, 4\u201313 (2019).","journal-title":"Trends Neurosci."},{"key":"1241_CR97","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier, D. J., Obeso, J. A. & Halliday, G. M. Selective neuronal vulnerability in Parkinson disease. Nat. Rev. Neurosci. 18, 101\u2013113 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"1241_CR98","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fneur.2018.00455","volume":"9","author":"N Giguere","year":"2018","unstructured":"Giguere, N., Burke Nanni, S. & Trudeau, L. E. On cell loss and selective vulnerability of neuronal populations in Parkinson\u2019s disease. Front. Neurol. 9, 455 (2018).","journal-title":"Front. Neurol."},{"key":"1241_CR99","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(18)30162-5","volume":"17","author":"K Knudsen","year":"2018","unstructured":"Knudsen, K. et al. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study. Lancet Neurol. 17, 618\u2013628 (2018).","journal-title":"Lancet Neurol."},{"key":"1241_CR100","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/mdc3.13687","volume":"10","author":"N Heng","year":"2023","unstructured":"Heng, N. et al. Striatal dopamine loss in early Parkinson\u2019s Disease: systematic review and novel analysis of dopamine transporter imaging. Mov. Disord. Clin. Pract. 10, 539\u2013546 (2023).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1241_CR101","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.smrv.2018.04.001","volume":"41","author":"M Bauckneht","year":"2018","unstructured":"Bauckneht, M. et al. Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: a systematic review and meta-analysis. Sleep Med. Rev. 41, 266\u2013274 (2018).","journal-title":"Sleep Med. Rev."},{"key":"1241_CR102","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/jnnp.2004.037028","volume":"76","author":"H Nagayama","year":"2005","unstructured":"Nagayama, H., Hamamoto, M., Ueda, M., Nagashima, J. & Katayama, Y. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 76, 249\u2013251 (2005).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1241_CR103","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/jnnp.67.2.189","volume":"67","author":"S Orimo","year":"1999","unstructured":"Orimo, S., Ozawa, E., Nakade, S., Sugimoto, T. & Mizusawa, H. 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 67, 189\u2013194 (1999).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1241_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25547-w","volume":"8","author":"L Barateau","year":"2018","unstructured":"Barateau, L. et al. Cardiac sympathetic activity differentiates idiopathic and symptomatic rapid eye movement sleep behaviour disorder. Sci. Rep. 8, 7304 (2018).","journal-title":"Sci. Rep."},{"key":"1241_CR105","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s00259-018-4183-0","volume":"46","author":"I Gabilondo","year":"2019","unstructured":"Gabilondo, I. et al. Myocardial MIBG scintigraphy in genetic Parkinson\u2019s disease as a model for Lewy body disorders. Eur. J. Nucl. Med. Mol. Imaging 46, 376\u2013384 (2019).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"1241_CR106","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.parkreldis.2009.12.010","volume":"16","author":"K Kashihara","year":"2010","unstructured":"Kashihara, K., Imamura, T. & Shinya, T. Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson\u2019s disease. Parkinsonism Relat. Disord. 16, 252\u2013255 (2010).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR107","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/RLU.0000000000002424","volume":"44","author":"DW Ryu","year":"2019","unstructured":"Ryu, D. W. et al. Initial versus follow-up sequential myocardial 123I-MIBG scintigraphy to discriminate Parkinson disease from atypical parkinsonian syndromes. Clin. Nucl. Med. 44, 282\u2013288 (2019).","journal-title":"Clin. Nucl. Med."},{"key":"1241_CR108","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/jnnp-2015-310327","volume":"86","author":"K Tsujikawa","year":"2015","unstructured":"Tsujikawa, K. et al. Chronological changes of 123I-MIBG myocardial scintigraphy and clinical features of Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 86, 945\u2013951 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1241_CR109","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.parkreldis.2022.08.006","volume":"103","author":"HK Kim","year":"2022","unstructured":"Kim, H. K. et al. Temporal trajectory model for dopaminergic input to the striatal subregions in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 103, 42\u201349 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR110","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1093\/brain\/awp209","volume":"132","author":"R Nandhagopal","year":"2009","unstructured":"Nandhagopal, R. et al. Longitudinal progression of sporadic Parkinson\u2019s disease: a multi-tracer positron emission tomography study. Brain 132, 2970\u20132979 (2009).","journal-title":"Brain"},{"key":"1241_CR111","doi-asserted-by":"publisher","unstructured":"Skjaerbaek, C. et al. Cardiac sympathetic degeneration informs the duration of the prodromal stage of body-first Lewy body disease. npj Parkinsons Dis. https:\/\/doi.org\/10.1038\/s41531-026-01455-z (2026).","DOI":"10.1038\/s41531-026-01455-z"},{"key":"1241_CR112","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3233\/JPD-191710","volume":"10","author":"S Sakakibara","year":"2020","unstructured":"Sakakibara, S. et al. Longitudinal change of DAT SPECT in Parkinson\u2019s disease and multiple system atrophy. J. Parkinsons Dis. 10, 123\u2013130 (2020).","journal-title":"J. Parkinsons Dis."},{"key":"1241_CR113","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.parkreldis.2022.09.016","volume":"104","author":"J Horsager","year":"2022","unstructured":"Horsager, J. et al. [18F]FEOBV positron emission tomography may not be a suitable method to measure parasympathetic denervation in patients with Parkinson\u2019s disease. Parkinsonism Relat. Disord. 104, 21\u201325 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR114","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad391","author":"N Okkels","year":"2023","unstructured":"Okkels, N. et al. Impaired cholinergic integrity of the colon and pancreas in dementia with Lewy bodies. Brain https:\/\/doi.org\/10.1093\/brain\/awad391 (2023).","journal-title":"Brain"},{"key":"1241_CR115","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.parkreldis.2022.07.005","volume":"101","author":"TD Fedorova","year":"2022","unstructured":"Fedorova, T. D. et al. Imaging progressive peripheral and central dysfunction in isolated REM sleep behaviour disorder after 3 years of follow-up. Parkinsonism Relat. Disord. 101, 99\u2013104 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR116","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41531-024-00844-6","volume":"10","author":"S Dong","year":"2024","unstructured":"Dong, S. et al. Comparison of vagus nerve cross-sectional area between brain-first and body-first Parkinson\u2019s disease. npj Parkinsons Dis. 10, 231 (2024).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR117","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00415-024-12783-6","volume":"272","author":"MS Kim","year":"2024","unstructured":"Kim, M. S., Park, D. G., Shin, I. J., An, Y. S. & Yoon, J. H. Gastric emptying time and its correlation with cardiac MIBG in body-first and brain-first subtype Parkinson\u2019s disease. J. Neurol. 272, 28 (2024).","journal-title":"J. Neurol."},{"key":"1241_CR118","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16497","volume":"31","author":"MS Kim","year":"2024","unstructured":"Kim, M. S. et al. Urodynamic study and its correlation with cardiac meta-iodobenzylguanidine (MIBG) in body-first and brain-first subtypes of Parkinson\u2019s disease. Eur. J. Neurol. 31, e16497 (2024).","journal-title":"Eur. J. Neurol."},{"key":"1241_CR119","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41531-021-00217-3","volume":"7","author":"SW Yoo","year":"2021","unstructured":"Yoo, S. W. et al. Cardiac sympathetic burden reflects Parkinson disease burden, regardless of high or low orthostatic blood pressure changes. npj Parkinsons Dis. 7, 71 (2021).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR120","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1212\/WNL.58.8.1247","volume":"58","author":"DS Goldstein","year":"2002","unstructured":"Goldstein, D. S., Holmes, C. S., Dendi, R., Bruce, S. R. & Li, S. T. Orthostatic hypotension from sympathetic denervation in Parkinson\u2019s disease. Neurology 58, 1247\u20131255 (2002).","journal-title":"Neurology"},{"key":"1241_CR121","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf023","volume":"7","author":"J Pasquini","year":"2025","unstructured":"Pasquini, J. et al. Substantia nigra and locus coeruleus microstructural abnormalities in isolated rapid eye movement sleep behaviour disorder and Parkinson\u2019s disease. Brain Commun. 7, fcaf023 (2025).","journal-title":"Brain Commun."},{"key":"1241_CR122","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/mds.29309","volume":"38","author":"A Nobileau","year":"2023","unstructured":"Nobileau, A. et al. Neuromelanin-sensitive magnetic resonance imaging changes in the locus coeruleus\/subcoeruleus complex in patients with typical and atypical parkinsonism. Mov. Disord. 38, 479\u2013484 (2023).","journal-title":"Mov. Disord."},{"key":"1241_CR123","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00702-023-02721-7","volume":"131","author":"G Palermo","year":"2024","unstructured":"Palermo, G. et al. Neurogenic orthostatic hypotension in Parkinson\u2019s disease: is there a role for locus coeruleus magnetic resonance imaging? J. Neural Transm. 131, 157\u2013164 (2024).","journal-title":"J. Neural Transm."},{"key":"1241_CR124","doi-asserted-by":"publisher","first-page":"911","DOI":"10.21037\/qims-24-1486","volume":"15","author":"Y Yang","year":"2025","unstructured":"Yang, Y., Zhang, M., Yan, Y., Chang, Y. & Chen, M. Relationship between freezing of gait in Parkinson disease and locus coeruleus dysfunction: a neuromelanin-sensitive magnetic resonance imaging study. Quant. Imaging Med. Surg. 15, 911\u2013920 (2025).","journal-title":"Quant. Imaging Med. Surg."},{"key":"1241_CR125","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1093\/brain\/awt152","volume":"136","author":"D Garcia-Lorenzo","year":"2013","unstructured":"Garcia-Lorenzo, D. et al. The coeruleus\/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson\u2019s disease. Brain 136, 2120\u20132129 (2013).","journal-title":"Brain"},{"key":"1241_CR126","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/brain\/awx348","volume":"141","author":"M Sommerauer","year":"2018","unstructured":"Sommerauer, M. et al. Evaluation of the noradrenergic system in Parkinson\u2019s disease: an 11C-MeNER PET and neuromelanin MRI study. Brain 141, 496\u2013504 (2018).","journal-title":"Brain"},{"key":"1241_CR127","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41531-023-00532-x","volume":"9","author":"J Sun","year":"2023","unstructured":"Sun, J. et al. Disruption of locus coeruleus-related functional networks in Parkinson\u2019s disease. npj Parkinsons Dis. 9, 81 (2023).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR128","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11682-024-00926-2","volume":"19","author":"J Fu","year":"2025","unstructured":"Fu, J. et al. Neuromelanin-MRI identifies locus coeruleus and substantia nigra degeneration as key differentiators in isolated rapid eye movement sleep behavior disorder. Brain Imaging Behav. 19, 72\u201381 (2025).","journal-title":"Brain Imaging Behav."},{"key":"1241_CR129","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/brain\/aww006","volume":"139","author":"M Ehrminger","year":"2016","unstructured":"Ehrminger, M. et al. The coeruleus\/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder. Brain 139, 1180\u20131188 (2016).","journal-title":"Brain"},{"key":"1241_CR130","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ana.22691","volume":"71","author":"V Kotagal","year":"2012","unstructured":"Kotagal, V. et al. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann. Neurol. 71, 560\u2013568 (2012).","journal-title":"Ann. Neurol."},{"key":"1241_CR131","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.5665\/sleep.5000","volume":"38","author":"D Arnaldi","year":"2015","unstructured":"Arnaldi, D. et al. The role of the serotonergic system in REM sleep behavior disorder. Sleep 38, 1505\u20131509 (2015).","journal-title":"Sleep"},{"key":"1241_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.107129","volume":"128","author":"R Shimasaki","year":"2024","unstructured":"Shimasaki, R. et al. Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and 123I-meta-iodobenzylguanidine cardiac scintigraphy in Parkinson\u2019s disease: multivariate analyses. Parkinsonism Relat. Disord. 128, 107129 (2024).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR133","doi-asserted-by":"publisher","first-page":"1298854","DOI":"10.3389\/frsle.2023.1298854","volume":"2","author":"M Garwood","year":"2024","unstructured":"Garwood, M., Vijayakumar, P., Bohnen, N. I., Koeppe, R. A. & Kotagal, V. Serotonin transporter density in isolated rapid eye movement sleep behavioral disorder. Front. Sleep 2, 1298854 (2024).","journal-title":"Front. Sleep"},{"key":"1241_CR134","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11682-024-00956-w","volume":"19","author":"AA Vijayakumari","year":"2025","unstructured":"Vijayakumari, A. A., Sakaie, K. E., Fernandez, H. H. & Walter, B. L. Parkinson\u2019s disease subtypes and their association with probable rapid eye movement sleep behavior disorder severity: a brainstem tractography and machine learning investigation. Brain Imaging Behav. 19, 189\u2013194 (2025).","journal-title":"Brain Imaging Behav."},{"key":"1241_CR135","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1002\/mds.29172","volume":"37","author":"M Banwinkler","year":"2022","unstructured":"Banwinkler, M., Dzialas, V., Parkinson\u2019s Progression Markers, I., Hoenig, M. C. & van Eimeren, T. Gray matter volume loss in proposed brain-first and body-first Parkinson\u2019s disease subtypes. Mov. Disord. 37, 2066\u20132074 (2022).","journal-title":"Mov. Disord."},{"key":"1241_CR136","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41531-024-00685-3","volume":"10","author":"SS Lovdal","year":"2024","unstructured":"Lovdal, S. S. et al. Investigating the aspect of asymmetry in brain-first versus body-first Parkinson\u2019s disease. npj Parkinsons Dis. 10, 74 (2024).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR137","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41531-025-01164-z","volume":"11","author":"G Palermo","year":"2025","unstructured":"Palermo, G. et al. Discriminating between proposed brain-first and body-first Parkinson\u2019s disease using conventional and radiomics-enhanced dopamine transporter SPECT image analysis. npj Parkinsons Dis. 11, 328 (2025).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR138","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41531-023-00507-y","volume":"9","author":"M Hattori","year":"2023","unstructured":"Hattori, M. et al. Clinico-imaging features of subjects at risk of Lewy body disease in NaT-PROBE baseline analysis. npj Parkinsons Dis. 9, 67 (2023).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR139","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3389\/fnins.2020.00349","volume":"14","author":"R Cao","year":"2020","unstructured":"Cao, R., Chen, X., Xie, C., Hu, P. & Wang, K. Serial dopamine transporter imaging of nigrostriatal function in Parkinson\u2019s disease with probable REM sleep behavior disorder. Front. Neurosci. 14, 349 (2020).","journal-title":"Front. Neurosci."},{"key":"1241_CR140","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/ene.13388","volume":"24","author":"SJ Chung","year":"2017","unstructured":"Chung, S. J., Lee, Y., Lee, J. J., Lee, P. H. & Sohn, Y. H. Rapid eye movement sleep behaviour disorder and striatal dopamine depletion in patients with Parkinson\u2019s disease. Eur. J. Neurol. 24, 1314\u20131319 (2017).","journal-title":"Eur. J. Neurol."},{"key":"1241_CR141","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3233\/JPD-212761","volume":"11","author":"K Knudsen,","year":"2021","unstructured":"Knudsen, K. et al. Asymmetric dopaminergic dysfunction in brain-first versus body-first Parkinson\u2019s disease subtypes. J. Parkinson\u2019s Dis. 11, 1677\u20131687 (2021).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"1241_CR142","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00415-024-12799-y","volume":"272","author":"CE Cicero","year":"2024","unstructured":"Cicero, C. E. et al. Exploring the relation between REM sleep behavior disorder onset and striatal dopaminergic dysfunction in Parkinson\u2019s disease. J. Neurol. 272, 75 (2024).","journal-title":"J. Neurol."},{"key":"1241_CR143","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3233\/JPD-230459","volume":"14","author":"KA Woo","year":"2024","unstructured":"Woo, K. A. et al. Symmetric and profound monoaminergic degeneration in Parkinson\u2019s disease with premotor REM sleep behavior disorder. J. Parkinsons Dis. 14, 823\u2013831 (2024).","journal-title":"J. Parkinsons Dis."},{"key":"1241_CR144","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/brain\/123.6.1155","volume":"123","author":"I Eisensehr","year":"2000","unstructured":"Eisensehr, I. et al. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson\u2019s disease and controls. Brain 123, 1155\u20131160 (2000).","journal-title":"Brain"},{"key":"1241_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105883","volume":"174","author":"DW Ryu","year":"2022","unstructured":"Ryu, D. W. et al. Comparison of disease progression between brain-predominant Parkinson\u2019s disease versus Parkinson\u2019s disease with body-involvement phenotypes. Neurobiol. Dis. 174, 105883 (2022).","journal-title":"Neurobiol. Dis."},{"key":"1241_CR146","doi-asserted-by":"publisher","unstructured":"Boertien, J. M. Striatal dopaminergic asymmetry as a marker of brain-first and body-first subtypes in de novo Parkinson\u2019s disease. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2022.12.23.22283910 (2022).","DOI":"10.1101\/2022.12.23.22283910"},{"key":"1241_CR147","doi-asserted-by":"publisher","unstructured":"Wang, J. et al. Nasal septum deviation correlates with asymmetry in Parkinson\u2019s disease. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2025.02.27.25322941 (2025).","DOI":"10.1101\/2025.02.27.25322941"},{"key":"1241_CR148","doi-asserted-by":"publisher","first-page":"e460","DOI":"10.1212\/WNL.0000000000011155","volume":"96","author":"N Pyatigorskaya","year":"2021","unstructured":"Pyatigorskaya, N. et al. Parkinson disease propagation using MRI biomarkers and partial least squares path modeling. Neurology 96, e460\u2013e471 (2021).","journal-title":"Neurology"},{"key":"1241_CR149","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41531-023-00556-3","volume":"9","author":"C Zhou","year":"2023","unstructured":"Zhou, C. et al. Two distinct trajectories of clinical and neurodegeneration events in Parkinson\u2019s disease. npj Parkinsons Dis. 9, 111 (2023).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR150","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41531-025-01037-5","volume":"11","author":"Y Oh","year":"2025","unstructured":"Oh, Y. et al. Clinical correlates of data-driven subtypes of deep gray matter atrophy and dopamine availability in early Parkinson\u2019s disease. npj Parkinsons Dis. 11, 165 (2025).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR151","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1093\/brain\/awae303","volume":"147","author":"Y Sakato","year":"2024","unstructured":"Sakato, Y. et al. Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson\u2019s disease. Brain 147, 3702\u20133713 (2024).","journal-title":"Brain"},{"key":"1241_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105753","volume":"117","author":"S Joza","year":"2025","unstructured":"Joza, S. et al. Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorder. EBioMedicine 117, 105753 (2025).","journal-title":"EBioMedicine"},{"key":"1241_CR153","doi-asserted-by":"publisher","DOI":"10.1002\/ana.78109","author":"S Yan","year":"2025","unstructured":"Yan, S. et al. Serum p-tau217 is a prognostic indicator of cognitive impairment in idiopathic REM sleep behavior disorder. Ann. Neurol. https:\/\/doi.org\/10.1002\/ana.78109 (2025).","journal-title":"Ann. Neurol."},{"key":"1241_CR154","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-021-02364-6","volume":"142","author":"EH Kok","year":"2021","unstructured":"Kok, E. H. et al. \u03b1-Synuclein pathology of olfactory bulbs\/peduncles in the Vantaa85+ cohort exhibit two divergent patterns: a population-based study. Acta Neuropathol. 142, 777\u2013780 (2021).","journal-title":"Acta Neuropathol."},{"key":"1241_CR155","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3233\/JPD-240019","volume":"14","author":"ER Dorsey","year":"2024","unstructured":"Dorsey, E. R., De Miranda, B. R., Horsager, J. & Borghammer, P. The body, the brain, the environment, and Parkinson\u2019s disease. J. Parkinsons Dis. 14, 363\u2013381 (2024).","journal-title":"J. Parkinsons Dis."},{"key":"1241_CR156","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49402-x","volume":"15","author":"SE Mastenbroek","year":"2024","unstructured":"Mastenbroek, S. E. et al. Disease progression modelling reveals heterogeneity in trajectories of Lewy-type \u03b1-synuclein pathology. Nat. Commun. 15, 5133 (2024).","journal-title":"Nat. Commun."},{"key":"1241_CR157","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00401-025-02918-y","volume":"150","author":"V Kivisto","year":"2025","unstructured":"Kivisto, V. et al. Myocardial sympathetic distal axon loss in subjects with Lewy pathology in three autopsy cohorts. Acta Neuropathol. 150, 11 (2025).","journal-title":"Acta Neuropathol."},{"key":"1241_CR158","doi-asserted-by":"publisher","first-page":"e1648","DOI":"10.1212\/WNL.0000000000200110","volume":"98","author":"T Matsubara","year":"2022","unstructured":"Matsubara, T. et al. Autopsy validation of the diagnostic accuracy of 123I-metaiodobenzylguanidine myocardial scintigraphy for Lewy body disease. Neurology 98, e1648\u2013e1659 (2022).","journal-title":"Neurology"},{"key":"1241_CR159","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1136\/jnnp-2015-310686","volume":"86","author":"M Takahashi","year":"2015","unstructured":"Takahashi, M. et al. Quantitative correlation between cardiac MIBG uptake and remaining axons in the cardiac sympathetic nerve in Lewy body disease. J. Neurol. Neurosurg. Psychiatry 86, 939\u2013944 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1241_CR160","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/mds.20594","volume":"20","author":"S Orimo","year":"2005","unstructured":"Orimo, S. et al. Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2. Mov. Disord. 20, 1350\u20131353 (2005).","journal-title":"Mov. Disord."},{"key":"1241_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.neures.2025.04.008","volume":"216","author":"N Uemura","year":"2025","unstructured":"Uemura, N. Fibril-seeded animal models of synucleinopathies: pathological mechanisms, disease modeling, and therapeutic implications. Neurosci. Res. 216, 104905 (2025).","journal-title":"Neurosci. Res."},{"key":"1241_CR162","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.3390\/ijms26093994","volume":"26","author":"R Takahashi","year":"2025","unstructured":"Takahashi, R., Yamakado, H., Uemura, N., Taguchi, T. & Ueda, J. The gut\u2013brain axis based on \u03b1-synuclein propagation-clinical, neuropathological, and experimental evidence. Int. J. Mol. Sci. 26, 3994 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"1241_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105599","volume":"163","author":"N Van Den Berge","year":"2022","unstructured":"Van Den Berge, N. & Ulusoy, A. Animal models of brain-first and body-first Parkinson\u2019s disease. Neurobiol. Dis. 163, 105599 (2022).","journal-title":"Neurobiol. Dis."},{"key":"1241_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/srep00898","volume":"2","author":"F Pan-Montojo","year":"2012","unstructured":"Pan-Montojo, F. et al. Environmental toxins trigger PD-like progression via increased \u03b1-synuclein release from enteric neurons in mice. Sci. Rep. 2, 898 (2012).","journal-title":"Sci. Rep."},{"key":"1241_CR165","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.642604","volume":"12","author":"G Schaffernicht","year":"2021","unstructured":"Schaffernicht, G. et al. Pathophysiological changes in the enteric nervous system of rotenone-exposed mice as early radiological markers for Parkinson\u2019s disease. Front. Neurol. 12, 642604 (2021).","journal-title":"Front. Neurol."},{"key":"1241_CR166","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","volume":"34","author":"JR Cannon","year":"2009","unstructured":"Cannon, J. R. et al. A highly reproducible rotenone model of Parkinson\u2019s disease. Neurobiol. Dis. 34, 279\u2013290 (2009).","journal-title":"Neurobiol. Dis."},{"key":"1241_CR167","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41531-025-01211-9","volume":"11","author":"Y Chen","year":"2025","unstructured":"Chen, Y. et al. Dairy-rich diet triggers hepatic \u03b1-synuclein pathology via the liver\u2013brain axis in GBA1-related Parkinson\u2019s disease. npj Parkinsons Dis. 11, 361 (2025).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105255","volume":"150","author":"X Yu","year":"2021","unstructured":"Yu, X. et al. Evaluation of blood flow as a route for propagation in experimental synucleinopathy. Neurobiol. Dis. 150, 105255 (2021).","journal-title":"Neurobiol. Dis."},{"key":"1241_CR169","doi-asserted-by":"publisher","first-page":"316","DOI":"10.7326\/M15-2421","volume":"165","author":"G Edgren","year":"2016","unstructured":"Edgren, G. et al. Transmission of neurodegenerative disorders through blood transfusion: a cohort study. Ann. Intern. Med. 165, 316\u2013324 (2016).","journal-title":"Ann. Intern. Med."},{"key":"1241_CR170","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41593-024-01866-2","volume":"28","author":"X Yuan","year":"2025","unstructured":"Yuan, X. et al. Propagation of pathologic \u03b1-synuclein from kidney to brain may contribute to Parkinson\u2019s disease. Nat. Neurosci. 28, 577\u2013588 (2025).","journal-title":"Nat. Neurosci."},{"key":"1241_CR171","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-019-02037-5","author":"S Lohmann","year":"2019","unstructured":"Lohmann, S. et al. Oral and intravenous transmission of \u03b1-synuclein fibrils to mice. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-019-02037-5 (2019).","journal-title":"Acta Neuropathol."},{"key":"1241_CR172","doi-asserted-by":"publisher","first-page":"e02095","DOI":"10.1128\/JVI.02095-16","volume":"91","author":"JI Ayers","year":"2017","unstructured":"Ayers, J. I. et al. Robust central nervous system pathology in transgenic mice following peripheral injection of \u03b1-synuclein fibrils. J. Virol. 91, e02095\u201316 (2017).","journal-title":"J. Virol."},{"key":"1241_CR173","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41531-025-01091-z","volume":"11","author":"JY Jeong","year":"2025","unstructured":"Jeong, J. Y. et al. Elevated plasma levels of \u03b1-synuclein are dispensable for Parkinson\u2019s disease pathology. npj Parkinsons Dis. 11, 228 (2025).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR174","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1084\/jem.20160368","volume":"213","author":"NL Rey","year":"2016","unstructured":"Rey, N. L. et al. Widespread transneuronal propagation of \u03b1-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson\u2019s disease. J. Exp. Med. 213, 1759\u20131778 (2016).","journal-title":"J. Exp. Med."},{"key":"1241_CR175","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.nbd.2016.12.013","volume":"109","author":"NL Rey","year":"2018","unstructured":"Rey, N. L., Wesson, D. W. & Brundin, P. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol. Dis. 109, 226\u2013248 (2018).","journal-title":"Neurobiol. Dis."},{"key":"1241_CR176","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29161","author":"M Sawamura","year":"2022","unstructured":"Sawamura, M. et al. Lewy body disease primate model with \u03b1-synuclein propagation from the olfactory bulb. Mov. Disord. https:\/\/doi.org\/10.1002\/mds.29161 (2022).","journal-title":"Mov. Disord."},{"key":"1241_CR177","doi-asserted-by":"publisher","unstructured":"Burtscher, J., Copin, J. C., Sandi, C. & Lashuel, H. A. Pronounced \u03b1-synuclein pathology in a seeding-based mouse model is not sufficient to induce mitochondrial respiration deficits in the striatum and amygdala. eNeuro https:\/\/doi.org\/10.1523\/ENEURO.0110-20.2020 (2020).","DOI":"10.1523\/ENEURO.0110-20.2020"},{"key":"1241_CR178","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/mds.26674","volume":"31","author":"P Mahlknecht","year":"2016","unstructured":"Mahlknecht, P. et al. Prodromal Parkinson\u2019s disease as defined per MDS research criteria in the general elderly community. Mov. Disord. 31, 1405\u20131408 (2016).","journal-title":"Mov. Disord."},{"key":"1241_CR179","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg, D. et al. MDS research criteria for prodromal Parkinson\u2019s disease. Mov. Disord. 30, 1600\u20131611 (2015).","journal-title":"Mov. Disord."},{"key":"1241_CR180","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14189-9","volume":"11","author":"XJ Wang","year":"2020","unstructured":"Wang, X. J. et al. Autonomic ganglionic injection of \u03b1-synuclein fibrils as a model of pure autonomic failure \u03b1-synucleinopathy. Nat. Commun. 11, 934 (2020).","journal-title":"Nat. Commun."},{"key":"1241_CR181","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim, S. et al. Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 103, 627\u2013641 e627 (2019).","journal-title":"Neuron"},{"key":"1241_CR182","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1093\/brain\/awaa283","volume":"143","author":"Y Shen","year":"2020","unstructured":"Shen, Y. et al. Propagated \u03b1-synucleinopathy recapitulates REM sleep behaviour disorder followed by parkinsonian phenotypes in mice. Brain 143, 3374\u20133392 (2020).","journal-title":"Brain"},{"key":"1241_CR183","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/brain\/awz380","volume":"143","author":"T Taguchi","year":"2020","unstructured":"Taguchi, T. et al. \u03b1-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson\u2019s disease model. Brain 143, 249\u2013265 (2020).","journal-title":"Brain"},{"key":"1241_CR184","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/brain\/aws358","volume":"136","author":"S Nuber","year":"2013","unstructured":"Nuber, S. et al. A progressive dopaminergic phenotype associated with neurotoxic conversion of \u03b1-synuclein in BAC-transgenic rats. Brain 136, 412\u2013432 (2013).","journal-title":"Brain"},{"key":"1241_CR185","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1002\/mds.28512","volume":"36","author":"N Uemura","year":"2021","unstructured":"Uemura, N. et al. \u03b1-Synuclein spread from olfactory bulb causes hyposmia, anxiety, and memory loss in BAC-SNCA mice. Mov. Disord. 36, 2036\u20132047 (2021).","journal-title":"Mov. Disord."},{"key":"1241_CR186","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/ng.3454","volume":"47","author":"JW Langston","year":"2015","unstructured":"Langston, J. W., Schule, B., Rees, L., Nichols, R. J. & Barlow, C. Multisystem Lewy body disease and the other parkinsonian disorders. Nat. Genet. 47, 1378\u20131384 (2015).","journal-title":"Nat. Genet."},{"key":"1241_CR187","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/mds.21701","volume":"23","author":"A Quattrone","year":"2008","unstructured":"Quattrone, A. et al. Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson\u2019s disease. Mov. Disord. 23, 21\u201327 (2008).","journal-title":"Mov. Disord."},{"key":"1241_CR188","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.parkreldis.2008.07.010","volume":"15","author":"K Hasegawa","year":"2009","unstructured":"Hasegawa, K. et al. Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes. Parkinsonism Relat. Disord. 15, 300\u2013306 (2009).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR189","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2169\/internalmedicine.45.1790","volume":"45","author":"K Itokawa","year":"2006","unstructured":"Itokawa, K., Tamura, N., Kawai, N., Shimazu, K. & Ishii, K. Parkinsonism in type I Gaucher\u2019s disease. Intern. Med. 45, 1165\u20131167 (2006).","journal-title":"Intern. Med."},{"key":"1241_CR190","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3233\/JPD-130333","volume":"4","author":"T Lebouvier","year":"2014","unstructured":"Lebouvier, T. et al. Peripheral autonomic nervous system involvement in Gaucher-related parkinsonism. J. Parkinson\u2019s Dis. 4, 29\u201332 (2014).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"1241_CR191","doi-asserted-by":"publisher","first-page":"935 e933","DOI":"10.1016\/j.neurobiolaging.2013.09.019","volume":"35","author":"Y Li","year":"2014","unstructured":"Li, Y. et al. Clinicogenetic study of GBA mutations in patients with familial Parkinson\u2019s disease. Neurobiol. Aging 35, 935 e933\u2013935 e938 (2014).","journal-title":"Neurobiol. Aging"},{"key":"1241_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34732-5","volume":"13","author":"L Krohn","year":"2022","unstructured":"Krohn, L. et al. Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects. Nat. Commun. 13, 7496 (2022).","journal-title":"Nat. Commun."},{"key":"1241_CR193","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1001\/jamaneurol.2021.3895","volume":"78","author":"NM Cocoros","year":"2021","unstructured":"Cocoros, N. M. et al. Long-term risk of Parkinson disease following influenza and other infections. JAMA Neurol. 78, 1461\u20131470 (2021).","journal-title":"JAMA Neurol."},{"key":"1241_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2025.103353","volume":"111","author":"J Liu","year":"2025","unstructured":"Liu, J. et al. Air pollution and Parkinson\u2019s disease: a prospective cohort study with sex-stratified analysis in the UK biobank. Neurotoxicology 111, 103353 (2025).","journal-title":"Neurotoxicology"},{"key":"1241_CR195","doi-asserted-by":"publisher","DOI":"10.1126\/science.adu4132","volume":"389","author":"X Zhang","year":"2025","unstructured":"Zhang, X. et al. Lewy body dementia promotion by air pollutants. Science 389, eadu4132 (2025).","journal-title":"Science"},{"key":"1241_CR196","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/jamaneurol.2018.0605","volume":"75","author":"I Peter","year":"2018","unstructured":"Peter, I. et al. Anti-tumor necrosis factor therapy and incidence of Parkinson disease among patients with inflammatory bowel disease. JAMA Neurol. 75, 939\u2013946 (2018).","journal-title":"JAMA Neurol."},{"key":"1241_CR197","doi-asserted-by":"publisher","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth, C. B. et al. Increased intestinal permeability correlates with sigmoid mucosa \u03b1-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS ONE 6, e28032 (2011).","journal-title":"PLoS ONE"},{"key":"1241_CR198","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans, F. et al. Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov. Disord. 30, 350\u2013358 (2015).","journal-title":"Mov. Disord."},{"key":"1241_CR199","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae098","volume":"6","author":"S Vingeliene","year":"2024","unstructured":"Vingeliene, S. et al. Hospital-treated infections and subsequent Parkinson\u2019s disease risk: a register-based sibling comparison study. Brain Commun. 6, fcae098 (2024).","journal-title":"Brain Commun."},{"key":"1241_CR200","doi-asserted-by":"publisher","first-page":"S297","DOI":"10.3233\/JPD-230419","volume":"14","author":"M Hu","year":"2024","unstructured":"Hu, M., Skjaerbaek, C. & Borghammer, P. Approaches to early Parkinson\u2019s disease subtyping. J. Parkinsons Dis. 14, S297\u2013S306 (2024).","journal-title":"J. Parkinsons Dis."},{"key":"1241_CR201","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/mds.28960","volume":"37","author":"Y Yuan","year":"2022","unstructured":"Yuan, Y. et al. High pesticide exposure events and dream-enacting behaviors among US farmers. Mov. Disord. 37, 962\u2013971 (2022).","journal-title":"Mov. Disord."},{"key":"1241_CR202","doi-asserted-by":"publisher","first-page":"e2214","DOI":"10.1212\/WNL.0000000000010610","volume":"95","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. Risk factors for possible REM sleep behavior disorders: a community-based study in Beijing. Neurology 95, e2214\u2013e2224 (2020).","journal-title":"Neurology"},{"key":"1241_CR203","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1212\/WNL.0000000000004496","volume":"89","author":"L Leclair-Visonneau","year":"2017","unstructured":"Leclair-Visonneau, L. et al. REM sleep behavior disorder is related to enteric neuropathology in Parkinson disease. Neurology 89, 1612\u20131618 (2017).","journal-title":"Neurology"},{"key":"1241_CR204","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/jnen\/nly074","volume":"77","author":"V Donadio","year":"2018","unstructured":"Donadio, V. et al. Skin nerve phosphorylated \u03b1-synuclein deposits in Parkinson disease with orthostatic hypotension. J. Neuropathol. Exp. Neurol. 77, 942\u2013949 (2018).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1241_CR205","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.24567","volume":"79","author":"V Donadio","year":"2016","unstructured":"Donadio, V. et al. Skin nerve misfolded \u03b1-synuclein in pure autonomic failure and Parkinson disease. Ann. Neurol. 79, 306\u2013316 (2016).","journal-title":"Ann. Neurol."},{"key":"1241_CR206","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jama.2024.0792","volume":"331","author":"CH Gibbons","year":"2024","unstructured":"Gibbons, C. H. et al. Skin biopsy detection of phosphorylated \u03b1-synuclein in patients with synucleinopathies. JAMA 331, 1298\u20131306 (2024).","journal-title":"JAMA"},{"key":"1241_CR207","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaf395","author":"M Liu","year":"2025","unstructured":"Liu, M. et al. Distinct cutaneous \u03b1-synuclein signatures in body-first and brain-first Parkinson\u2019s disease subtypes. Brain https:\/\/doi.org\/10.1093\/brain\/awaf395 (2025).","journal-title":"Brain"},{"key":"1241_CR208","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41531-024-00806-y","volume":"10","author":"M Kurihara","year":"2024","unstructured":"Kurihara, M. et al. \u03b1-Synuclein seed amplification assay sensitivity may be associated with cardiac MIBG abnormality among patients with Lewy body disease. npj Parkinsons Dis. 10, 190 (2024).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR209","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00401-025-02904-4","volume":"149","author":"A Mastrangelo","year":"2025","unstructured":"Mastrangelo, A. et al. Quantification of Lewy body pathology by cerebrospinal fluid endpoint dilution RT-QuIC in a neuropathological autopsy cohort of clinically heterogeneous participants. Acta Neuropathol. 149, 67 (2025).","journal-title":"Acta Neuropathol."},{"key":"1241_CR210","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU Hoglinger","year":"2024","unstructured":"Hoglinger, G. U. et al. A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol. 23, 191\u2013204 (2024).","journal-title":"Lancet Neurol."},{"key":"1241_CR211","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni, T. et al. A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research. Lancet Neurol. 23, 178\u2013190 (2024).","journal-title":"Lancet Neurol."},{"key":"1241_CR212","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/mdc3.14089","volume":"11","author":"RB Postuma","year":"2024","unstructured":"Postuma, R. B. et al. Anticipating tomorrow: tailoring Parkinson\u2019s symptomatic therapy using predictors of outcome. Mov. Disord. Clin. Pract. 11, 983\u2013991 (2024).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1241_CR213","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJMoa2202867","volume":"387","author":"G Pagano","year":"2022","unstructured":"Pagano, G. et al. Trial of prasinezumab in early-stage Parkinson\u2019s disease. N. Engl. J. Med. 387, 421\u2013432 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1241_CR214","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0140-6736(24)02808-3","volume":"405","author":"N Vijiaratnam","year":"2025","unstructured":"Vijiaratnam, N. et al. Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson\u2019s disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial. Lancet 405, 627\u2013636 (2025).","journal-title":"Lancet"},{"key":"1241_CR215","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa2203395","volume":"387","author":"AE Lang","year":"2022","unstructured":"Lang, A. E. et al. Trial of cinpanemab in early Parkinson\u2019s disease. N. Engl. J. Med. 387, 408\u2013420 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1241_CR216","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1093\/brain\/awae061","volume":"147","author":"V Pesch","year":"2024","unstructured":"Pesch, V. et al. Vaccination with structurally adapted fungal protein fibrils induces immunity to Parkinson\u2019s disease. Brain 147, 1644\u20131652 (2024).","journal-title":"Brain"},{"key":"1241_CR217","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awag010","author":"L Ma","year":"2026","unstructured":"Ma, L. et al. Vaccines mimicking conformational epitopes on \u03b1-synuclein fibrils provide immunity to Parkinson\u2019s disease. Brain https:\/\/doi.org\/10.1093\/brain\/awag010 (2026).","journal-title":"Brain"},{"key":"1241_CR218","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-024-02886-y","volume":"30","author":"G Pagano","year":"2024","unstructured":"Pagano, G. et al. Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson\u2019s disease. Nat. Med. 30, 1096\u20131103 (2024).","journal-title":"Nat. Med."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01241-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01241-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01241-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T12:03:11Z","timestamp":1787832191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01241-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":218,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1241"],"URL":"https:\/\/doi.org\/10.1038\/s41582-026-01241-8","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"22 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}